What’s Happening 
in AAV Gene Therapy Now

Viralgen accelerates clinical development process: scaling manufacturing and completing GMP production of Trogenix’s AAV gene therapy in under 12 months.

Patients with CTNNB1 Syndrome will benefit from this joint effort to develop and manufacture a new AAV investigational gene therapy, which aims to restore gene function and may improve quality of...

Collaborative effort will bring hope to BBS patients suffering from retinal degeneration through this investigational gene therapy.

Collaborative efforts focus on developing AAV gene therapy to treat prion disease.

As part of our ongoing commitment to building a greener and more responsible future, we are happy to announce the completion of the installation of 540 solar panels in one of our facilities. This...

This month, we had the honor of welcoming Lehendakari Imanol Pradales and key members of his government team to our facilities; Mikel Jauregi, Minister of Industry, Energy Transition and...

Viralgen inaugurated its new MSAT (Manufacturing, Science and Technology) laboratory today at the Science and Technology Park of the Basque Country in Donostia. Opening this laboratory marks a...

On Friday 14 April, the leader of Spain's Partido Popular, Alberto Núñez Feijóo, visited our facilities, where he had the opportunity of seeing the entire development and manufacturing process of...

The ‌Basque National Orchestra has debuted in Poland with a tour of four concerts. The first concert of the tour of the Euskadiko Orkestra took place in Warsaw as part of the Beethoven Easter...

On March 6, we welcomed Susana Solís Pérez, Member of the European Parliament, the Committee on Regional Development (REGI) and vice-president of the Delegation for Relations with the Korean...

The mayor of San Sebastian, Eneko Goia, presented on Friday, January 20, the Tambor de Oro 2023 – a highly prestigious recognition – to Javier García Cogorro during the ceremony celebrated in the...